Intellectus Partners’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Intellectus Partners’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31,082	Closed	-$2K	–	596
2018 Q3	$2K	Hold	31,082	–	–	﹤0.01%	561
2018 Q2	$6K	Hold	31,082	–	–	﹤0.01%	526
2018 Q1	$11K	Buy	+31,082	New	+$14.8K	﹤0.01%	475

Intellectus Partners's IMNP Position: Q4 2018 in Review

Intellectus Partners sold out of Immune Pharmaceuticals Inc. (IMNP) in Q4 2018, closing a stake of 31,082 shares — an estimated $2K sold.

Intellectus Partners first reported a position in IMNP in Q1 2018 and held it in 3 quarters. The position peaked at $11K in Q1 2018. 0 funds tracked by Wall St. Rank hold IMNP as of Q4 2018.

Intellectus Partners reported no remaining Immune Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
Intellectus Partners sold 31,082 Immune Pharmaceuticals Inc. shares in Q4 2018, an estimated $2K.
Intellectus Partners first reported a position in Immune Pharmaceuticals Inc. in Q1 2018 and held it in 3 quarters.
Intellectus Partners's Immune Pharmaceuticals Inc. position peaked at $11K in Q1 2018.
0 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.